IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kinnevik AB (publ)

Q3 2025 Holdings

Filed 2025-11-04 | 1 holdings | $65.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Recursion Pharmaceuticals, Inc.(RXRX)CL A75629V104$65.6M13,434,171100.0%